peri-menopause

Patients

One of the biggest challenges for women in their 40s and 50s going through the menopause is the recognition that one size does not fit all.

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.